136 related articles for article (PubMed ID: 5745277)
21. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
Hansen J; Andersen OS
Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
[No Abstract] [Full Text] [Related]
22. [Early detection and treatment of Wilson's disease].
Sternlieb I
Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):859-62. PubMed ID: 5834270
[No Abstract] [Full Text] [Related]
23. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
24. Penicillamine and the SLE syndrome.
Walshe JM
J Rheumatol Suppl; 1981; 7():155-60. PubMed ID: 6939878
[TBL] [Abstract][Full Text] [Related]
25. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
Walshe JM
Lancet; 1969 Dec; 2(7635):1401-2. PubMed ID: 4188283
[No Abstract] [Full Text] [Related]
26. Management of hepatolenticular degeneration (Wilson's disease).
Traugh G
Arch Phys Med Rehabil; 1971 Mar; 52(3):126-9. PubMed ID: 5575151
[No Abstract] [Full Text] [Related]
27. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of Wilson's disease].
Hoogenraad TU; van Hattum J
Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
[No Abstract] [Full Text] [Related]
29. [Wilson's disease treated by penicillamine: favorable effect].
Petit H
Lille Med; 1968 Dec; 13(10):1132-4. PubMed ID: 5711646
[No Abstract] [Full Text] [Related]
30. [Wilson's disease treated with penicillamine (author's transl)].
Aksamija-Rizvić B
Lijec Vjesn; 1976 Aug; 98(8):430-1. PubMed ID: 1004094
[No Abstract] [Full Text] [Related]
31. [Wilson's disease].
Bonfissuto G; Magliarisi C; Soresi M; Bascone F; Costanza G; Carroccio A; Montalto G
Recenti Prog Med; 1997 Jan; 88(1):40-5. PubMed ID: 9102715
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Wilson's disease.
Richardson JC
Mod Treat; 1968 Mar; 5(2):321-31. PubMed ID: 5655947
[No Abstract] [Full Text] [Related]
33. Hepatolenticular degeneration (Wilson's disease).
Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
[No Abstract] [Full Text] [Related]
34. [Hepatocerebral degeneration (Wilson's disease). 2. Therapy].
Werner T; Weinmann H
Med Klin; 1965 Nov; 60(46):1856-9. PubMed ID: 5884683
[No Abstract] [Full Text] [Related]
35. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
[TBL] [Abstract][Full Text] [Related]
36. [D-penicillamine and cutaneous lesions in Wilson's disease].
Peiró Grasa A; Barnadas Andiñach M; Moreno Carazo A; Grau-Veciana JM
Neurologia; 1986; 1(2):88-9. PubMed ID: 2978898
[No Abstract] [Full Text] [Related]
37. [Electrophysiological changes of the brain in Wilson's disease under D-penicillamine treatment].
Fujita T; Fujita H; Okawa M; Yokoi S
Rinsho Shinkeigaku; 1976 May; 16(5):381-8. PubMed ID: 986276
[No Abstract] [Full Text] [Related]
38. [Therapy of neurologic manifestations of Wilson's disease using penicillamine].
Hartl J; Hauftová D
Cesk Neurol; 1970 Mar; 33(2):89-93. PubMed ID: 5417217
[No Abstract] [Full Text] [Related]
39. [Therapeutic effects of penicillamine on Wilson's disease].
Takagi H; Yoshida K; Okamura S; Maehashi M
Nihon Rinsho; 1965 Oct; 23(10):2038-44. PubMed ID: 5895380
[No Abstract] [Full Text] [Related]
40. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
Bell GE; Slivka DC; Huston JR
J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
